Subscribe to RSS - FDA

FDA

Invacare faces lawsuit from shareholder

 - 
05/31/2013

ELYRIA, Ohio – Invacare officials will “vigorously defend” themselves against new allegations that they misled shareholders about the company’s noncompliance with Food and Drug Administration (FDA) regulations, according to a spokeswoman.

FDA approves Breathe Technologies’ CPAP device

 - 
05/31/2013

IRVINE, Calif. – Breathe Technologies, a manufacturer of respiratory products, had its CPAP system cleared by the Food and Drug Administration (FDA), according to a press release.

Invacare restructures credit agreement

 - 
05/30/2013

ELYRIA, Ohio – Invacare has amended its credit agreement, giving the company greater financial flexibility for the remainder of 2013, according to a press release.

Investor files suit against Invacare

 - 
05/28/2013

ELYRIA, Ohio – A shareholder of Invacare Corporation has filed a lawsuit in the U.S. District Court for the Northern District of Ohio over alleged violations of federal securities laws by the company, according to a press release.

Invacare clears first FDA hurdle

 - 
05/14/2013

ELYRIA, Ohio – Invacare announced May 13 that the Food and Drug Administration (FDA) has approved the first of three audits, allowing the company to resume certain production at its Taylor Street facility.

Invacare acknowledges 'difficult time'

HME sales, down 13.6% in first quarter, continue to drag
 - 
04/26/2013

ELYRIA, Ohio – Invacare in April submitted two audits to the Food and Drug Administration (FDA) for approval, but it’s an accomplishment that has been overshadowed by another poor earnings showing.

ResMed 'plans to stay ahead of the game'

 - 
04/26/2013

SAN DIEGO – Despite pervasive reimbursement pressures, ResMed officials have reported solid earnings for the third quarter and outlined “major growth horizons” for the company’s future.

FDA approves ResMed vent for COPD patients

 - 
04/25/2013

SAN DIEGO – The Food and Drug Administration (FDA) has cleared ResMed’s variable positive airway pressure (VPAP) device for the treatment of COPD, according to a press release.

Invacare to release earnings, discuss FDA audits

 - 
04/10/2013

ELYRIA, Ohio – Invacare will release its financial results for the first quarter of 2013 before the market opens on Thursday, April 25, according to a press release. In a conference call scheduled that same day at 8:30 a.m.

Sales suffer at Invacare

‘Our new orders aren’t what they were a year ago’
 - 
04/09/2013

ELYRIA, Ohio – In a big sign that an agreement with the Food and Drug Administration (FDA) is dampening sales, Invacare has announced that it has laid off an additional 68 employees at its manufacturing facility on Taylor Street.

Pages